Adjuvant effect of Gantrez®AN nanoparticles during oral vaccination of piglets against F4+enterotoxigenic Escherichia coli

Veterinary Immunology and Immunopathology

Volumn 139, Issue 2-4, 2011, Pages 148-155

  Vandamme, Katrien ^a   Vesna, Melkebeek ^a   Eric, Cox ^a   Paul, Remon Jean ^a   Chris, Vervaet ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

F4 fimbriae; F4+ Escherichia coli; Gantrez AN nanoparticles; Oral vaccination

Indexed keywords

ESCHERICHIA COLI VACCINE; GANTREZ AN; GANTREZ COPOLYMER; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; UNCLASSIFIED DRUG; WHEAT GERM AGGLUTININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG EFFECT; DRUG FORMULATION; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FIMBRIA; IMMUNOREACTIVITY; INFECTION RESISTANCE; INTESTINE CELL; NANOENCAPSULATION; NONHUMAN; PIGLET; TARGET CELL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; BACTERIAL SHEDDING; BACTERIAL VACCINES; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FIMBRIAE PROTEINS; MALEATES; NANOPARTICLES; POLYVINYLS; SWINE; SWINE DISEASES; WHEAT GERM AGGLUTININS;

ESCHERICHIA COLI; SUIDAE; TRITICUM AESTIVUM;

EID: 78650868204     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2010.09.009     Document Type: Article

References (44)

1. Alexander T.J.L. Neonatal diarrhoea in pigs. Escherichia coli in Domestic Animals and Humans 1994, 151-170. CAB International, Oxon. C.L. Gyles (Ed.).
2. Arbos P., Arangoa M.A., Campanero M.A., Irache J.M. Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles. Int. J. Pharm. 2002, 242:129-136.
3. Arbos P., Campanero M.A., Arnangoa M.A., Renedo M.J., Irache J.M. Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties. J. Control. Rel. 2003, 89:19-30.
4. Bijlsma I.G.W., Bouw J. Inheritance of K88-mediated adhesion of Escherichia coli to jejunal brush-borders in pigs - a genetical-analysis. Vet. Res. Commun. 1987, 11:509-518.
5. Blanco M., Blanco J.E., Gonzalez E.A., Mora A., Jansen W., Gomes T.A.T., Zerbini L.F., Yano T., DeCastro A.F.P., Blanco J. Genes coding for enterotoxins and verotoxins in porcine Escherichia coli strains belonging to different O:K:H serotypes: relationship with toxic phenotypes. J. Clin. Microbiol. 1997, 35:2958-2963.
6. Bozic F., Lackovic G., Stokes C.R., Valpotic I. Recruitment of intestinal CD45RA+ and CD45RC+ cells induced by a candidate oral vaccine against porcine post-weaning colibacillosis. Vet. Immunol. Immunopathol. 2002, 86:137-146.
7. Choi B.Y., Sohn Y.S., Choi C., Chae C. Lectin histochemistry for glycoconjugates in the small intestines of piglets naturally infected with Isospora suis. J. Vet. Med. Sci. 2003, 65:389-392.
8. Clark M.A., Hirst B.H., Jepson M.A. Lectin-mediated mucosal delivery of drugs and microparticles. Adv. Drug Deliv. Rev. 2000, 43:207-223.
9. Cox E., Schrauwen E., Cools V., Houvenaghel A. Experimental induction of diarrhea in newly weaned piglets. J. Vet. Med. Ser. A-Zent. bl. Vet. Med. Reihe A-Physiol. Pathol. Clin. Med. 1991, 38:418-426.
10. Crawley A., Raymond C., Wilkie B.N. Control of immunoglobulin isotype production by porcine B-cells cultured with cytokines. Vet. Immunol. Immunopathol. 2003, 91:141-154.
11. de Geus B., Harmsen M., van Zijderveld F. Prevention of diarrhoea using pathogen specific monoclonal antibodies in an experimental enterotoxigenic E. coli infection in germfree piglets. International Symposium on Gastro-Intestinal Disorders in Juveniles 1997, S87-S89.
12. Devriendt B., Stuyven E., Verdonck F., Goddeeris B.M., Cox E. Enterotoxigenic Escherichia coli (K88) induce proinflammatory responses in porcine intestinal epithelial cells. Dev. Comp. Immunol 2010.
13. Erickson A.K., Willgohs J.A., McFarland S.Y., Benfield D.A., Francis D.H. Identification of two porcine brush border glycoproteins that bind the K88ac adhesin of Escherichia coli and correlation of these glycoproteins with the adhesive phenotype. Infect. Immun. 1992, 60:983-988.
14. Eyles J.E., Carpenter Z.C., Alpar H.O., Williamson E.D. Immunological aspects of polymer microsphere vaccine delivery systems. J. Drug Target. 2004, 11:509-514.
15. Fairbrother J.M., Nadeau E., Gyles C.L. Escherichia coli in postweaning diarrhea in pigs: an update on bacterial types. Anim. Health Res. Rev. 2005, 6:17-39.
16. Gabor F., Bogner E., Weissenboeck A., Wirth M. The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery. Adv. Drug Deliv. Rev. 2004, 56:459-480.
17. Galindo-Rodriguez S.A., Allemann E., Fessi H., Doelker E. Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies. Crit. Rev. Ther. Drug Carrier Syst. 2005, 22:419-463.
18. Gomez S., Gamazo C., Roman B.S., Vauthier C., Ferrer M., Irache J.M. Development of a novel vaccine delivery system based on Gantrez nanoparticles. J. Nanosci. Nanotechnol. 2006, 6:3283-3289.
19. Gomez S., Gamazo C., San Roman B., Ferrer M., Sanz M.L., Irache J.M. Gantrez((R)) AN nanoparticles as an adjuvant for oral immunotherapy with allergens. Vaccine 2007, 25:5263-5271.
20. Hampson D.J. Postweaning Escherichia coli diarrhoea in pigs. Escherichia coli in Domestic Animals and Humans 1994, 171-191. CAB International, Oxon. C.L. Gyles (Ed.).
21. Lavelle E.C., Grant G., Pusztai A., Pfuller U., O'Hagan D.T. The identification of plant lectins with mucosal adjuvant activity. Immunology 2001, 102:77-86.
22. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
23. Melkebeek V., Sonck E., Verdonck F., Goddeeris B.M., Cox E. Optimized FaeG expression and a thermolabile enterotoxin DNA adjuvant enhance priming of an intestinal immune response by an FaeG DNA vaccine in pigs. Clin. Vaccine Immunol. 2007, 14:28-35.
24. Moon H.W., Bunn T.O. Vaccines for preventing enterotoxigenic Escherichia coli infections in farm animals. Vaccine 1993, 11:200-213.
25. Roth-Walter F., Scholl I., Untersmayr E., Fuchs R., Boltz-Nitulescu G., Weissenbock A., Scheiner O., Gabor F., Jensen-Jarolim E. M cell targeting with Ateuria aurantia lectin as a novel approach for oral allergen immunotherapy. J. Allergy Clin. Immunol. 2004, 114:1362-1368.
26. Salman H.H., Gamazo C., de Smidt P.C., Russell-Jones G., Irache J.M. Evaluation of bioadhesive capacity and immunoadjuvant properties of vitamin B-12-Gantrez nanoparticles. Pharm. Res. 2008, 25:2859-2868.
27. Salman H.H., Gomez S., Gamazo C., Martins R.C., Zabaleta V., Irache J.M. Micro-organism-like nanoparticles for oral antigen delivery. J. Drug Deliv. Sci. Technol. 2008, 18:31-39.
28. Sarrazin E., Bertschinger H.U. Role of fimbriae F18 for actively acquired immunity against porcine enterotoxigenic Escherichia coli. Vet. Microbiol. 1997, 54:133-144.
29. Schmidt U., Zschoche S., Werner C. Modification of poly(octadecene-alt-maleic anhydride) films by reaction with functional amines. J. Appl. Polym. Sci. 2003, 87:1255-1266.
30. Van den Broeck W., Cox E., Goddeeris B.M. Induction of immune responses in pigs following oral administration of purified F4 fimbriae. Vaccine 1999, 17:2020-2029.
31. Van den Broeck W., Cox E., Goddeeris B.M. Receptor-dependent immune responses in pigs after oral immunization with F4 fimbriae. Infect. Immun. 1999, 67:520-526.
32. Van den Broeck W., Cox E., Goddeeris B.M. Receptor-specific binding of purified F4 to isolated villi. Vet. Microbiol. 1999, 68:255-263.
33. Van der Stede Y., Cox E., Goddeeris B.M. Antigen dose modulates the immunoglobulin isotype responses of pigs against intramuscularly administered F4-fimbriae. Vet. Immunol. Immunopathol. 2002, 88:209-216.
34. Van der Stede Y., Cox E., Van den Broeck W., Goddeeris B.M. Enhanced induction of the IgA response in pigs by calcitriol after intramuscular immunization. Vaccine 2001, 19:1870-1878.
35. Van Zaane D., Hulst M.M. Monoclonal antibodies against porcine immunoglobulin isotypes. Vet. Immunol. Immunopathol. 1987, 16:23-36.
36. Vandamme K., Melkebeek V., Cox E., Deforce D., Lenoir J., Adriaens E., Vervaet C., Remon J.P. Influence of reaction medium during synthesis of Gantrez(R) AN 119 nanoparticles for oral vaccination. Eur. J. Pharm. Biopharm. 2010, 74:202-208.
37. Vazquez F., Gonzalez E.A., Garabal J.I., Valderrama S., Blanco J., Baloda S.B. Development and evaluation of an ELISA to detect Escherichia coli K88 (F4) fimbrial antibody levels. J. Med. Microbiol. 1996, 44:453-463.
38. Verdonck F., Cox E., Schepers E., Imberechts H., Joensuu J., Goddeeris B.M. Conserved regions in the sequence of the F4 (K88) fimbrial adhesin FaeG suggest a donor strand mechanism in F4 assembly. Vet. Microbiol. 2004, 102:215-225.
39. Verdonck F., Cox E., Van der Stede Y., Goddeeris B.M. Oral immunization of piglets with recombinant F4 fimbrial adhesin FaeG monomers induces a mucosal and systemic F4-specific immune response. Vaccine 2004, 22:4291-4299.
40. Verdonck F., Snoeck V., Goddeeris B.M., Cox E. Binding of a monoclonal antibody positively correlates with bioactivity of the F4 fimbrial adhesin FaeG associated with post-weaning diarrhoea in piglets. J. Immunol. Methods 2004, 294:81-88.
41. Walter F., Scholl I., Untersmayr E., Ellinger A., Boltz-Nitulescu G., Scheiner O., Gabor F., Jensen-Jarolim E. Functionalisation of allergen-loaded microspheres with wheat germ agglutinin for targeting enterocytes. Biochem. Biophys. Res. Commun. 2004, 315:281-287.
42. Wilkie B., Mallard B. Selection for high immune response: an alternative approach to animal health maintenance?. Vet. Immunol. Immunopathol. 1999, 72:231-235.
43. Wirth M., Hamilton G., Gabor F. Lectin-mediated drug targeting: quantification of binding and internalization of Wheat germ agglutinin and Solanum tuberosum lectin using Caco-2 and HT-29 cells. J. Drug Target. 1998, 6:95-104.
44. Xiang S.D., Scholzen A., Minigo G., David C., Apostolopoulos V., Mottram P.L., Plebanski M. Pathogen recognition and development of particulate vaccines: does size matter?. Methods 2006, 40:1-9.